The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Bavarian Nordic's ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.

As safety flags hang over Valneva’s chikungunya vaccine in the U.S. and beyond, French authorities are clamping down on the shot’s use in older adults. | France’s public health agency has temporarily ...

Shares in Valneva plunged after the company said France's health authorities suspended the use of its chikungunya vaccine, Ixchiq, for people aged 65 and older, raising concerns about the vaccine's ...

According to Benzinga, the approval is a milestone not only for Brazil but also for regions struggling with chikungunya ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its ...

Dianne Elliot took a three-week, seven-country trip that included stops in the United Kingdom, Egypt, India, Cambodia, Jordan, Indonesia and Oman. Some of those countries require ...

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

A panel of federal health experts recommended expanded vaccine options for several diseases, including RSV, meningitis, and chikungunya.

GSK also secured an ACIP recommendation for its new meningococcal vaccine, Penmenvy. In chikungunya vaccines, Bavarian Nordic’s Vimkunya received an affirmative ACIP vote. But Valneva’s ...

The ACIP voted to recommend a precaution related to the use of Ixchiq in patients aged 65 years and older. Recommendations for the use of chikungunya vaccine were recently discussed at a meeting ...